Abdelmalik Slassi
Fortune : 59 000 $ au 31/05/2026
Fortune : 59 000 $ au 31/05/2026
Abdelmalik Slassi was the founder of Mindset Pharma, Inc., founded in 2019, holding the title of Senior Vice President-Innovation.
Dr. Slassi is also the founder of Fluorinov Pharma, Inc...
Dr. Slassi is currently Director at Pharmala Biotech, Inc. Former positions include Director & Vice President-Medicinal Chemistry at NPS Pharmaceuticals, Inc., Independent Director at Pharmala Biotech Holdings, Inc. from 2021 to 2026, Director & VP-Manufacturing & Drug Development at Cascade Therapeutics, Inc., and Senior Vice President-Drug Discovery Research at Trillium Therapeutics, Inc. from 2016 to 2019.
Education includes a doctorate from Université Claude Bernard Lyon 1.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/05/2025 | 500 000 ( 0,46 % ) | 59 000 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Membre du Conseil | 09/02/2026 |
| TRILLIUM THERAPEUTICS | Corporate Officer/Principal | 01/12/2019 |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Fondateur | 01/01/2016 |
| MINDSET PHARMA INC. | Fondateur | - |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Commercial Services |
Mindset Pharma, Inc.
Mindset Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for psychiatric and neurological disorders | Health Technology |
PharmAla Biotech Holdings, Inc.
PharmAla Biotech Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and sells pharmaceutical ingredients | Health Technology |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national